Shivam Autotech Ltd has scheduled a board meeting for October 8, 2026, to finalize the critical terms of its upcoming Rights Issue. The board will determine the issue price, entitlement ratio, and record date for existing shareholders. Additionally, the company confirmed that the trading window remains closed in accordance with insider trading norms ahead of the quarterly financial results declaration.
Shivam Autotech to Finalize Rights Issue Terms on October 8
October 8, 2026: Board meeting to determine pricing and record date
October 1, 2026: Trading window closed for insider trading compliance
Reader Takeaway: The upcoming board meeting will clarify the cost and dilution impact of the planned Rights Issue.
What just happened
Shivam Autotech Ltd has formally scheduled a board meeting for October 8, 2026, to advance its fund-raising plans. The company is set to finalize the specifics of its Rights Issue, a corporate action originally approved by the board on July 1, 2026. The meeting will result in the disclosure of the issue price, the entitlement ratio for existing shareholders, and the crucial record date for eligibility.
Why this matters
For existing shareholders, the October 8 outcome is the most significant development in the fundraise process. Investors will finally have the data necessary to calculate the potential dilution of their holdings and the financial commitment required to participate in the Rights Issue. The company is also preparing its Letter of Offer and associated legal documentation during this session.
What changes now
The company’s trading window for securities has been closed since October 1, 2026. This is a standard governance procedure mandated by insider trading regulations. Because the board is reviewing both the Rights Issue terms and the unaudited financial results for the quarter and half-year ended September 30, 2026, the window will remain shut. It will reopen only 48 hours after the company publicly declares its financial results.
What to track next
Investors should look for the official exchange filing following the October 8 meeting. This filing will provide the definitive record date, which determines who is eligible to apply for the new shares. Monitoring the subsequent announcement of the company’s Q2 financial performance is also essential to gauge the underlying health of the business during this capital-raising phase.
